Alkaloid [EPC]

Alkaloid [EPC] was reported 26665 times

These side effects are most commonly reported by patients taking drugs of the Alkaloid [EPC] class:

# Drug class Count
0 DIARRHOEA 2458
1 OFF LABEL USE 2256
2 DRUG INEFFECTIVE 2052
3 NAUSEA 1818
4 FATIGUE 1644
5 DYSPNOEA 1373
6 ARTHRALGIA 1356
7 ACUTE KIDNEY INJURY 1325
8 HEADACHE 1280
9 TOXICITY TO VARIOUS AGENTS 1269
10 VOMITING 1253
11 PAIN 1136
12 DRUG INTERACTION 1131
13 GOUT 1108
14 RASH 994
15 PYREXIA 909
16 CONDITION AGGRAVATED 891
17 RENAL FAILURE 880
18 ASTHENIA 867
19 MALAISE 832
20 ABDOMINAL PAIN 808
21 DIZZINESS 797
22 DEATH 755
23 PNEUMONIA 755
24 HYPOTENSION 752
25 DRUG INTOLERANCE 729
26 COUGH 709
27 DRUG HYPERSENSITIVITY 699
28 PAIN IN EXTREMITY 672
29 CHRONIC KIDNEY DISEASE 654
30 WEIGHT DECREASED 641
31 CHEST PAIN 634
32 HYPERTENSION 611
33 FALL 608
34 PRURITUS 583
35 ANAEMIA 564
36 PERIPHERAL SWELLING 550
37 BACK PAIN 546
38 ERYTHEMA 540
39 DECREASED APPETITE 538
40 RHABDOMYOLYSIS 531
41 OVERDOSE 530
42 MYALGIA 522
43 ABDOMINAL DISCOMFORT 519
44 THROMBOCYTOPENIA 513
45 PRODUCT USE IN UNAPPROVED INDICATION 475
46 OEDEMA PERIPHERAL 453
47 RHEUMATOID ARTHRITIS 446
48 ASPARTATE AMINOTRANSFERASE INCREASED 445
49 ABDOMINAL PAIN UPPER 443
50 PERICARDITIS 443
51 TREATMENT FAILURE 433
52 ALANINE AMINOTRANSFERASE INCREASED 432
53 JOINT SWELLING 427
54 MULTIPLE ORGAN DYSFUNCTION SYNDROME 426
55 PANCYTOPENIA 422
56 RENAL IMPAIRMENT 421
57 WEIGHT INCREASED 421
58 DEHYDRATION 413
59 INSOMNIA 413
60 PRODUCT USE ISSUE 410
61 ATRIAL FIBRILLATION 409
62 HYPERSENSITIVITY 409
63 CARDIAC FAILURE CONGESTIVE 408
64 CONSTIPATION 398
65 ARTHRITIS 380
66 GENERAL PHYSICAL HEALTH DETERIORATION 376
67 BLOOD CREATININE INCREASED 366
68 SEPSIS 361
69 URINARY TRACT INFECTION 360
70 BLOOD PRESSURE INCREASED 357
71 ANXIETY 356
72 COMPLETED SUICIDE 354
73 COVID-19 354
74 URTICARIA 354
75 CARDIAC FAILURE 348
76 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 348
77 MUSCULOSKELETAL STIFFNESS 346
78 NEUTROPENIA 340
79 CONTRAINDICATED PRODUCT ADMINISTERED 339
80 GAIT DISTURBANCE 339
81 INFECTION 337
82 RENAL FAILURE ACUTE 336
83 GASTROINTESTINAL DISORDER 332
84 C-REACTIVE PROTEIN INCREASED 328
85 PERICARDIAL EFFUSION 324
86 ALOPECIA 319
87 HAEMOGLOBIN DECREASED 314
88 INTENTIONAL OVERDOSE 314
89 PRODUCT DOSE OMISSION ISSUE 312
90 METABOLIC ACIDOSIS 310
91 INFLAMMATION 309
92 MUSCULAR WEAKNESS 307
93 NASOPHARYNGITIS 300
94 GASTROINTESTINAL HAEMORRHAGE 299
95 THERAPY NON-RESPONDER 296
96 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 293
97 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 291
98 DEPRESSION 288
99 INFUSION RELATED REACTION 288
100 CARDIAC ARREST 283
101 MYOCARDIAL INFARCTION 283
102 MUSCLE SPASMS 281
103 SOMNOLENCE 277
104 PSORIATIC ARTHROPATHY 276
105 SYNOVITIS 268
106 HYPOAESTHESIA 267
107 CONFUSIONAL STATE 266
108 C-REACTIVE PROTEIN ABNORMAL 262
109 CHILLS 260
110 RASH PRURITIC 259
111 PARAESTHESIA 257
112 FEELING ABNORMAL 256
113 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 256
114 LOSS OF CONSCIOUSNESS 256
115 TENOSYNOVITIS 254
116 PLEURAL EFFUSION 250
117 BLOOD GLUCOSE INCREASED 248
118 LEUKOPENIA 247
119 ENTHESOPATHY 245
120 TENDONITIS 245
121 HEPATIC ENZYME INCREASED 242
122 END STAGE RENAL DISEASE 241
123 RESPIRATORY FAILURE 241
124 SKIN ULCER 239
125 ULCER 237
126 CONTUSION 236
127 HYPERKALAEMIA 235
128 THERAPEUTIC PRODUCT EFFECT DECREASED 232
129 MYOPATHY 231
130 CELLULITIS 230
131 TONGUE DISORDER 229
132 ABDOMINAL DISTENSION 220
133 HYPERHIDROSIS 218
134 LEUKOCYTOSIS 218
135 INJECTION SITE PAIN 214
136 THERAPEUTIC RESPONSE DECREASED 214
137 PALPITATIONS 213
138 SWELLING 212
139 CEREBROVASCULAR ACCIDENT 207
140 HEART RATE INCREASED 207
141 BASAL CELL CARCINOMA 206
142 EPISTAXIS 206
143 CARDIOGENIC SHOCK 201
144 TREMOR 201
145 INTENTIONAL PRODUCT USE ISSUE 200
146 OEDEMA 199
147 MOBILITY DECREASED 195
148 OROPHARYNGEAL PAIN 195
149 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 195
150 HYPERCALCAEMIA 194
151 INTERNATIONAL NORMALISED RATIO INCREASED 194
152 NEUROPATHY PERIPHERAL 194
153 SYNCOPE 190
154 DRUG ERUPTION 188
155 PANNICULITIS 188
156 SINUSITIS 188
157 GASTROOESOPHAGEAL REFLUX DISEASE 185
158 TACHYCARDIA 185
159 BLOOD CREATINE PHOSPHOKINASE INCREASED 184
160 DYSPHAGIA 184
161 BEHCET^S SYNDROME 183
162 CHEST DISCOMFORT 183
163 ARTHROPATHY 180
164 BLOOD PRESSURE SYSTOLIC INCREASED 180
165 PLATELET COUNT DECREASED 180
166 SUICIDE ATTEMPT 180
167 DRY MOUTH 175
168 SHOCK 175
169 HOSPITALISATION 174
170 ANGIOEDEMA 173
171 DYSPEPSIA 173
172 DISEASE RECURRENCE 172
173 OSTEOARTHRITIS 171
174 INFLUENZA 169
175 INCORRECT DOSE ADMINISTERED 168
176 SEPTIC SHOCK 168
177 RED BLOOD CELL SEDIMENTATION RATE INCREASED 167
178 VISION BLURRED 166
179 WHITE BLOOD CELL COUNT DECREASED 166
180 BLOOD PRESSURE DECREASED 164
181 SKIN NECROSIS 164
182 PULMONARY OEDEMA 163
183 RHEUMATOID NODULE 163
184 HAEMATURIA 161
185 HYPONATRAEMIA 160
186 VISUAL IMPAIRMENT 158
187 BLOOD PARATHYROID HORMONE DECREASED 157
188 CARDIAC DISORDER 157
189 LETHARGY 157
190 NECK PAIN 155
191 DRUG RESISTANCE 154
192 RENAL INJURY 154
193 DISEASE PROGRESSION 152
194 HAEMORRHAGE 152
195 HYPOKALAEMIA 152
196 CATARACT 151
197 PSORIASIS 151
198 LIVER DISORDER 150
199 ASTHMA 149
200 DIABETES MELLITUS 149
201 HEPATIC STEATOSIS 149
202 PRODUCTIVE COUGH 149
203 HALLUCINATION 148
204 ILLNESS 148
205 DRY SKIN 146
206 FLUID RETENTION 146
207 HEPATIC FAILURE 146
208 BLISTER 145
209 BRONCHITIS 145
210 LYMPHADENOPATHY 144
211 LACTIC ACIDOSIS 141
212 ALANINE AMINOTRANSFERASE ABNORMAL 140
213 FLUSHING 140
214 GRANULOMA SKIN 139
215 HYPOXIA 139
216 JOINT INJURY 138
217 RENAL DISORDER 138
218 DYSPHONIA 137
219 NEPHROGENIC ANAEMIA 137
220 CORONARY ARTERY DISEASE 136
221 OSTEOPOROSIS 136
222 RHINORRHOEA 136
223 ANAPHYLACTIC REACTION 134
224 BONE MARROW FAILURE 133
225 CHOLESTASIS 132
226 STRESS 132
227 OXYGEN SATURATION DECREASED 131
228 PULMONARY EMBOLISM 131
229 NASAL CONGESTION 130
230 DYSPNOEA EXERTIONAL 129
231 RED BLOOD CELL SEDIMENTATION RATE 128
232 BRADYCARDIA 126
233 COAGULOPATHY 125
234 MULTI-ORGAN FAILURE 125
235 FEBRILE NEUTROPENIA 124
236 HAEMATOCHEZIA 124
237 MYOCARDITIS 124
238 ACUTE RESPIRATORY FAILURE 123
239 INTERSTITIAL LUNG DISEASE 123
240 EXPOSURE DURING PREGNANCY 122
241 NEPHROLITHIASIS 122
242 ADVERSE EVENT 121
243 DISSEMINATED INTRAVASCULAR COAGULATION 121
244 HEPATIC FUNCTION ABNORMAL 121
245 MEMORY IMPAIRMENT 121
246 RASH MACULO-PAPULAR 121
247 HOT FLUSH 120
248 MOUTH ULCERATION 118
249 ACUTE MYOCARDIAL INFARCTION 117
250 INJURY 117
251 WHEEZING 117
252 ADVERSE DRUG REACTION 116
253 BURNING SENSATION 115
254 GASTRIC DISORDER 115
255 INJECTION SITE ERYTHEMA 115
256 SKIN DISORDER 115
257 RECTAL HAEMORRHAGE 114
258 SYSTEMIC LUPUS ERYTHEMATOSUS 112
259 HYPOGLYCAEMIA 111
260 INTENTIONAL PRODUCT MISUSE 111
261 DISCOMFORT 110
262 THROMBOSIS 110
263 EMOTIONAL DISTRESS 108
264 FLATULENCE 108
265 HEPATOTOXICITY 108
266 MIGRAINE 108
267 SLEEP DISORDER 108
268 TREATMENT NONCOMPLIANCE 108
269 UPPER RESPIRATORY TRACT INFECTION 108
270 BALANCE DISORDER 107
271 MEDICATION ERROR 107
272 ARRHYTHMIA 106
273 BLOOD UREA INCREASED 106
274 TUBULOINTERSTITIAL NEPHRITIS 106
275 WHITE BLOOD CELL COUNT INCREASED 106
276 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 105
277 MUSCULOSKELETAL PAIN 105
278 BLOOD PRESSURE FLUCTUATION 104
279 HEPATIC CYTOLYSIS 104
280 SWELLING FACE 104
281 LIVER INJURY 102
282 PANCREATITIS ACUTE 102
283 RESPIRATORY DISTRESS 102
284 BLOOD URIC ACID INCREASED 101
285 BONE PAIN 101
286 DEEP VEIN THROMBOSIS 101
287 DRUG-INDUCED LIVER INJURY 101
288 LIVER FUNCTION TEST ABNORMAL 101
289 CROHN^S DISEASE 99
290 HYPOCALCAEMIA 99
291 UNEVALUABLE EVENT 99
292 PANCREATITIS 98
293 CARDIOMYOPATHY 96
294 LIVER FUNCTION TEST INCREASED 96
295 RESPIRATORY TRACT INFECTION 96
296 WOUND 96
297 ACCIDENTAL OVERDOSE 95
298 STAPHYLOCOCCAL INFECTION 95
299 DRUG TOLERANCE DECREASED 94
300 EYE PAIN 94
301 HEART RATE DECREASED 94
302 SKIN EXFOLIATION 94
303 STOMATITIS 94
304 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 94
305 ASCITES 93
306 HAEMOPTYSIS 93
307 INJECTION SITE REACTION 93
308 HEART RATE IRREGULAR 92
309 MATERNAL EXPOSURE DURING PREGNANCY 92
310 PULMONARY HYPERTENSION 92
311 EOSINOPHILIA 91
312 HEPATITIS 91
313 STEVENS-JOHNSON SYNDROME 90
314 TOXIC EPIDERMAL NECROLYSIS 90
315 FEELING HOT 89
316 UPPER GASTROINTESTINAL HAEMORRHAGE 89
317 CARDIO-RESPIRATORY ARREST 88
318 MELAENA 88
319 MYELOSUPPRESSION 88
320 NEUROMYOPATHY 88
321 OSTEOMYELITIS 88
322 CARDIAC TAMPONADE 87
323 HEART FAILURE WITH PRESERVED EJECTION FRACTION 87
324 HERPES ZOSTER 87
325 TRANSAMINASES INCREASED 87
326 FEAR OF INJECTION 86
327 HYPERPARATHYROIDISM SECONDARY 86
328 HYPOMAGNESAEMIA 86
329 JOINT STIFFNESS 85
330 LOSS OF EMPLOYMENT 85
331 LUNG DISORDER 85
332 ACUTE RESPIRATORY DISTRESS SYNDROME 84
333 DRUG DOSE OMISSION 84
334 HYPERSENSITIVITY VASCULITIS 84
335 INTESTINAL OBSTRUCTION 84
336 AGRANULOCYTOSIS 82
337 DYSGEUSIA 82
338 DYSSTASIA 82
339 LIMB INJURY 82
340 MENTAL STATUS CHANGES 82
341 THERAPY INTERRUPTED 82
342 HAEMATEMESIS 81
343 SKIN DISCOLOURATION 81
344 ANHEDONIA 80
345 BLOOD POTASSIUM DECREASED 80
346 GAIT INABILITY 80
347 HYPERGLYCAEMIA 80
348 HYPERLIPIDAEMIA 80
349 MUSCULOSKELETAL DISORDER 80
350 VENTRICULAR TACHYCARDIA 80
351 HAEMATOCRIT DECREASED 79
352 INJECTION SITE BRUISING 79
353 PULMONARY FIBROSIS 79
354 ACUTE HEPATIC FAILURE 78
355 BLOOD CHOLESTEROL INCREASED 78
356 DELIRIUM 78
357 MYOSITIS 78
358 PAIN IN JAW 78
359 BLOOD ALKALINE PHOSPHATASE INCREASED 77
360 CARDIOMEGALY 77
361 VERTIGO 77
362 AGITATION 76
363 THERAPY PARTIAL RESPONDER 76
364 VASCULITIS 76
365 ATELECTASIS 75
366 RASH ERYTHEMATOUS 75
367 SEIZURE 75
368 SKIN LESION 75
369 CLOSTRIDIUM DIFFICILE INFECTION 74
370 COLITIS 74
371 LIP SWELLING 74
372 RENAL FAILURE CHRONIC 74
373 HEPATOCELLULAR INJURY 73
374 NO ADVERSE EVENT 73
375 PALLOR 72
376 TENDERNESS 72
377 ECZEMA 71
378 RED BLOOD CELL COUNT DECREASED 71
379 RENAL TUBULAR NECROSIS 71
380 ECONOMIC PROBLEM 70
381 SPEECH DISORDER 70
382 SUICIDAL IDEATION 70
383 SURGERY 70
384 THROAT IRRITATION 70
385 ILL-DEFINED DISORDER 69
386 INFLUENZA LIKE ILLNESS 69
387 LOWER RESPIRATORY TRACT INFECTION 68
388 REBOUND EFFECT 68
389 SLEEP APNOEA SYNDROME 68
390 ANGINA PECTORIS 67
391 CHOLELITHIASIS 67
392 LIMB DISCOMFORT 67
393 NIGHT SWEATS 67
394 ORAL PAIN 67
395 PREMATURE BABY 67
396 PRODUCT DOSE OMISSION 67
397 TRANSIENT ISCHAEMIC ATTACK 67
398 BODY TEMPERATURE DECREASED 66
399 GRANULOMA 66
400 FAMILIAL MEDITERRANEAN FEVER 65
401 FOETAL EXPOSURE DURING PREGNANCY 65
402 PNEUMONIA ASPIRATION 65
403 HYPOPHAGIA 64
404 LOCALISED INFECTION 64
405 PULMONARY MASS 64
406 UVEITIS 64
407 AMNESIA 63
408 BLOOD LACTATE DEHYDROGENASE INCREASED 63
409 GAMMA-GLUTAMYLTRANSFERASE INCREASED 63
410 HAEMATOMA 63
411 INFUSION SITE PAIN 63
412 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 63
413 LUPUS NEPHRITIS 63
414 OCULAR HYPERAEMIA 63
415 DRY EYE 62
416 INJECTION SITE PRURITUS 62
417 TROPONIN INCREASED 62
418 HEAD INJURY 61
419 HYPOTHYROIDISM 61
420 INJECTION SITE SWELLING 61
421 VIRAL INFECTION 61
422 GASTRITIS 60
423 MUSCLE ATROPHY 60
424 SINUS CONGESTION 60
425 APPETITE DISORDER 59
426 CUTANEOUS VASCULITIS 59
427 EAR PAIN 59
428 ELECTROCARDIOGRAM QT PROLONGED 59
429 GLAUCOMA 59
430 OBESITY 59
431 PNEUMONITIS 59
432 POLLAKIURIA 59
433 GASTRIC ULCER 58
434 TYPE 2 DIABETES MELLITUS 58
435 URINE OUTPUT DECREASED 58
436 BLOOD PRESSURE DIASTOLIC DECREASED 57
437 DISORIENTATION 57
438 DIVERTICULITIS 57
439 DRUG TOLERANCE 57
440 DYSURIA 57
441 HAEMORRHOIDS 57
442 JOINT RANGE OF MOTION DECREASED 57
443 MUCOSAL INFLAMMATION 57
444 SEROSITIS 57
445 ASPIRATION 56
446 GENERALISED OEDEMA 56
447 GLOMERULAR FILTRATION RATE DECREASED 56
448 IMPAIRED HEALING 56
449 NERVOUSNESS 56
450 RASH MACULAR 56
451 SJOGREN^S SYNDROME 56
452 APHTHOUS ULCER 55
453 CEREBRAL HAEMORRHAGE 55
454 EJECTION FRACTION DECREASED 55
455 FAECES DISCOLOURED 55
456 GOUTY ARTHRITIS 55
457 MITRAL VALVE INCOMPETENCE 55
458 PULMONARY ARTERIAL HYPERTENSION 55
459 SEASONAL ALLERGY 55
460 CLOSTRIDIUM DIFFICILE COLITIS 54
461 HYPOACUSIS 54
462 MYOPATHY TOXIC 54
463 PURPURA 54
464 SNEEZING 54
465 SPLENOMEGALY 54
466 SWOLLEN TONGUE 54
467 TOOTH DISORDER 54
468 URINARY RETENTION 54
469 DEPRESSED LEVEL OF CONSCIOUSNESS 53
470 DYSARTHRIA 53
471 PRODUCT ADMINISTRATION ERROR 53
472 SINUS TACHYCARDIA 53
473 TRICUSPID VALVE INCOMPETENCE 53
474 ATRIAL FLUTTER 52
475 BLOOD POTASSIUM INCREASED 52
476 HIP FRACTURE 52
477 INFUSION SITE ERYTHEMA 52
478 JOINT EFFUSION 52
479 STILL^S DISEASE 52
480 COLITIS ULCERATIVE 51
481 COMA 51
482 DRUG DEPENDENCE 51
483 PHOTOPHOBIA 51
484 PREMATURE DELIVERY 51
485 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 50
486 FOOT FRACTURE 50
487 PERICARDIAL HAEMORRHAGE 50
488 RESPIRATORY ACIDOSIS 50
489 RIB FRACTURE 50
490 TACHYPNOEA 50
491 ARTHRITIS INFECTIVE 49
492 DRUG LEVEL INCREASED 49
493 EAR INFECTION 49
494 FLUID OVERLOAD 49
495 ILEUS 49
496 JAUNDICE 49
497 PRESYNCOPE 49
498 RESPIRATORY DISORDER 49
499 TENDON RUPTURE 49
500 BLOOD BILIRUBIN INCREASED 48
501 CARDIOVASCULAR DISORDER 48
502 COGNITIVE DISORDER 48
503 HAEMODYNAMIC INSTABILITY 48
504 HYPERSOMNIA 48
505 PROTEINURIA 48
506 TINNITUS 48
507 TOXIC SKIN ERUPTION 48
508 VENTRICULAR FIBRILLATION 48
509 CENTRAL NERVOUS SYSTEM LUPUS 47
510 MALIGNANT NEOPLASM PROGRESSION 47
511 PRODUCT PRESCRIBING ISSUE 47
512 SERUM AMYLOID A PROTEIN INCREASED 47
513 TASTE DISORDER 47
514 THERAPY CESSATION 47
515 ACCIDENTAL EXPOSURE TO PRODUCT 46
516 BLOOD GLUCOSE DECREASED 46
517 BODY MASS INDEX ABNORMAL 46
518 CYSTITIS 46
519 FAECES SOFT 46
520 HYPOVOLAEMIA 46
521 MOVEMENT DISORDER 46
522 MUSCULOSKELETAL DISCOMFORT 46
523 NEURALGIA 46
524 RHEUMATOID LUNG 46
525 RIGHT VENTRICULAR FAILURE 46
526 ACIDOSIS 45
527 BLOOD PRESSURE SYSTOLIC DECREASED 45
528 BODY TEMPERATURE INCREASED 45
529 CANDIDA INFECTION 45
530 DIVERTICULUM 45
531 FIBROMYALGIA 45
532 FOOD ALLERGY 45
533 LYMPHOCYTE COUNT DECREASED 45
534 MUSCULOSKELETAL CHEST PAIN 45
535 OLIGURIA 45
536 ORAL HERPES 45
537 ROAD TRAFFIC ACCIDENT 45
538 SKIN PLAQUE 45
539 VITAMIN D DECREASED 45
540 ADRENAL INSUFFICIENCY 44
541 BLINDNESS 44
542 BLOOD URINE PRESENT 44
543 CARPAL TUNNEL SYNDROME 44
544 LYMPHOPENIA 44
545 NEUTROPHIL COUNT DECREASED 44
546 ORTHOSTATIC HYPOTENSION 44
547 PETECHIAE 44
548 PLEURISY 44
549 PRODUCT QUALITY ISSUE 44
550 RASH GENERALISED 44
551 UNRESPONSIVE TO STIMULI 44
552 ABASIA 43
553 BLOOD PRESSURE ABNORMAL 43
554 BLOOD SODIUM DECREASED 43
555 DEAFNESS 43
556 EYE SWELLING 43
557 CONJUNCTIVITIS 42
558 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 42
559 ELECTROLYTE IMBALANCE 42
560 EYE IRRITATION 42
561 GASTROENTERITIS 42
562 HYPERURICAEMIA 42
563 INJECTION SITE HAEMORRHAGE 42
564 INJECTION SITE RASH 42
565 INTENTIONAL DOSE OMISSION 42
566 ORTHOPNOEA 42
567 PLATELET COUNT INCREASED 42
568 RESTLESS LEGS SYNDROME 42
569 SKIN IRRITATION 42
570 ABDOMINAL PAIN LOWER 41
571 ANURIA 41
572 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 41
573 CONCOMITANT DISEASE AGGRAVATED 41
574 DRUG TOXICITY 41
575 HEPATIC CIRRHOSIS 41
576 HEPATITIS ACUTE 41
577 HYPOKINESIA 41
578 IMPAIRED GASTRIC EMPTYING 41
579 INTERVERTEBRAL DISC PROTRUSION 41
580 NEPHROPATHY 41
581 PHARYNGITIS 41
582 REBOUND ACID HYPERSECRETION 41
583 THROAT TIGHTNESS 41
584 BACTERIAL INFECTION 40
585 BLOOD CALCIUM DECREASED 40
586 BLOOD PRESSURE DIASTOLIC ABNORMAL 40
587 DEPRESSED MOOD 40
588 DEVICE ISSUE 40
589 EYE DISORDER 40
590 HYDRONEPHROSIS 40
591 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 40
592 MYOPERICARDITIS 40
593 OSTEOPENIA 40
594 PHARYNGITIS STREPTOCOCCAL 40
595 SINUS DISORDER 40
596 ANAPHYLACTIC SHOCK 39
597 BLOOD TRIGLYCERIDES INCREASED 39
598 BURSITIS 39
599 CONVULSION 39
600 DERMATITIS 39
601 DYSKINESIA 39
602 GENERALISED ERYTHEMA 39
603 GOUTY TOPHUS 39
604 KIDNEY INFECTION 39
605 NEUTROPHILIA 39
606 SHOCK HAEMORRHAGIC 39
607 TOOTHACHE 39
608 URINARY INCONTINENCE 39
609 ABDOMINAL TENDERNESS 38
610 ABNORMAL BEHAVIOUR 38
611 ABNORMAL LOSS OF WEIGHT 38
612 ABSCESS 38
613 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 38
614 CIRCULATORY COLLAPSE 38
615 DEMENTIA 38
616 FLANK PAIN 38
617 GLUCOSE TOLERANCE IMPAIRED 38
618 HYPERVOLAEMIA 38
619 IMMUNODEFICIENCY 38
620 LACRIMATION INCREASED 38
621 MALNUTRITION 38
622 MENTAL DISORDER 38
623 MIXED LIVER INJURY 38
624 QUALITY OF LIFE DECREASED 38
625 WEIGHT FLUCTUATION 38
626 CORONARY ARTERY OCCLUSION 37
627 DIABETES MELLITUS INADEQUATE CONTROL 37
628 FULL BLOOD COUNT DECREASED 37
629 FUNGAL INFECTION 37
630 HYPOVOLAEMIC SHOCK 37
631 IRON DEFICIENCY ANAEMIA 37
632 MYELODYSPLASTIC SYNDROME 37
633 PRODUCT PRESCRIBING ERROR 37
634 THROMBOCYTOSIS 37
635 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 36
636 AGEUSIA 36
637 CYTOMEGALOVIRUS INFECTION 36
638 DRUG EFFECT DECREASED 36
639 LABORATORY TEST ABNORMAL 36
640 POLYARTHRITIS 36
641 POOR QUALITY SLEEP 36
642 RASH PAPULAR 36
643 RENAL CYST 36
644 RESTLESSNESS 36
645 RETCHING 36
646 SCAR 36
647 SCIATICA 36
648 SKIN HYPERPIGMENTATION 36
649 THINKING ABNORMAL 36
650 CRYING 35
651 DIABETIC KETOACIDOSIS 35
652 ENCEPHALOPATHY 35
653 EPISCLERITIS 35
654 ERECTILE DYSFUNCTION 35
655 FACE OEDEMA 35
656 FEELING COLD 35
657 HAEMORRHAGIC DIATHESIS 35
658 HALLUCINATION, VISUAL 35
659 HIATUS HERNIA 35
660 HYPERAESTHESIA 35
661 HYPERPHOSPHATAEMIA 35
662 ISCHAEMIC STROKE 35
663 MYOCARDIAL ISCHAEMIA 35
664 NEOPLASM MALIGNANT 35
665 NERVOUS SYSTEM DISORDER 35
666 NEUTROPHIL COUNT INCREASED 35
667 PLASMA CELL MYELOMA 35
668 RESPIRATORY ARREST 35
669 UNDERDOSE 35
670 VENTRICULAR EXTRASYSTOLES 35
671 ACNE 34
672 CARDIAC DYSFUNCTION 34
673 CARDIAC FAILURE ACUTE 34
674 CHOLECYSTITIS 34
675 DIALYSIS 34
676 DYSPHORIA 34
677 GRIP STRENGTH DECREASED 34
678 GROWTH RETARDATION 34
679 HYPERTRANSAMINASAEMIA 34
680 INJECTION SITE URTICARIA 34
681 IRRITABILITY 34
682 NEPHROGENIC SYSTEMIC FIBROSIS 34
683 PHOTOSENSITIVITY REACTION 34
684 PYODERMA GANGRENOSUM 34
685 SERUM FERRITIN INCREASED 34
686 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 33
687 ACTIVITIES OF DAILY LIVING IMPAIRED 33
688 BRAIN FOG 33
689 DISTURBANCE IN ATTENTION 33
690 DYSLIPIDAEMIA 33
691 ECHOCARDIOGRAM ABNORMAL 33
692 FREQUENT BOWEL MOVEMENTS 33
693 GASTROENTERITIS VIRAL 33
694 JAUNDICE CHOLESTATIC 33
695 MYOCLONUS 33
696 OSTEONECROSIS 33
697 PULMONARY CONGESTION 33
698 RESPIRATORY RATE INCREASED 33
699 SQUAMOUS CELL CARCINOMA 33
700 ALTERED STATE OF CONSCIOUSNESS 32
701 ANKYLOSING SPONDYLITIS 32
702 CYANOSIS 32
703 CYTOLYTIC HEPATITIS 32
704 DIZZINESS POSTURAL 32
705 DRUG ABUSE 32
706 EMOTIONAL DISORDER 32
707 EYE HAEMORRHAGE 32
708 PARALYSIS 32
709 PRODUCT SUBSTITUTION ISSUE 32
710 PROTHROMBIN TIME PROLONGED 32
711 PULSELESS ELECTRICAL ACTIVITY 32
712 RALES 32
713 THERAPEUTIC RESPONSE UNEXPECTED 32
714 BENIGN PROSTATIC HYPERPLASIA 31
715 CARDIAC MURMUR 31
716 CHONDROCALCINOSIS 31
717 COLD SWEAT 31
718 HEART RATE ABNORMAL 31
719 HYPERTHYROIDISM 31
720 INJECTION SITE WARMTH 31
721 MASS 31
722 PERITONITIS 31
723 PSYCHOTIC DISORDER 31
724 SKIN CANCER 31
725 SKIN WARM 31
726 SPINAL OSTEOARTHRITIS 31
727 ARTERIOSCLEROSIS 30
728 CHROMATURIA 30
729 CYTOPENIA 30
730 DIABETIC NEUROPATHY 30
731 ENTEROCOLITIS 30
732 FRACTURE 30
733 GALLBLADDER DISORDER 30
734 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 30
735 HYPERCHOLESTEROLAEMIA 30
736 INFUSION SITE SWELLING 30
737 LEFT VENTRICULAR DYSFUNCTION 30
738 LYMPHOMA 30
739 SKIN BURNING SENSATION 30
740 SPINAL FRACTURE 30
741 TUBERCULOSIS 30
742 WHITE BLOOD CELLS URINE POSITIVE 30
743 APHASIA 29
744 ARTERIOSCLEROSIS CORONARY ARTERY 29
745 ATRIOVENTRICULAR BLOCK 29
746 BLOOD ALBUMIN DECREASED 29
747 BLOOD GLUCOSE ABNORMAL 29
748 BUNDLE BRANCH BLOCK RIGHT 29
749 CONJUNCTIVAL HAEMORRHAGE 29
750 DRUG WITHDRAWAL SYNDROME 29
751 ESSENTIAL HYPERTENSION 29
752 FEAR 29
753 HERNIA 29
754 PRESCRIBED OVERDOSE 29
755 PROSTATE CANCER 29
756 RED CELL DISTRIBUTION WIDTH INCREASED 29
757 THERAPEUTIC RESPONSE SHORTENED 29
758 UPPER LIMB FRACTURE 29
759 WRONG PRODUCT ADMINISTERED 29
760 BLOOD LACTIC ACID INCREASED 28
761 EPILEPSY 28
762 ERYTHEMA NODOSUM 28
763 GINGIVAL BLEEDING 28
764 HEPATOSPLENOMEGALY 28
765 HEREDITARY ANGIOEDEMA 28
766 METASTASES TO LUNG 28
767 POST PROCEDURAL INFECTION 28
768 PRODUCT DOSE OMISSION IN ERROR 28
769 ROTATOR CUFF SYNDROME 28
770 URTICARIAL VASCULITIS 28
771 VITAMIN D DEFICIENCY 28
772 AGGRESSION 27
773 ANGIOPATHY 27
774 BLOOD COUNT ABNORMAL 27
775 BREATH SOUNDS ABNORMAL 27
776 CYST 27
777 DEFAECATION DISORDER 27
778 DERMATITIS ATOPIC 27
779 DERMATITIS EXFOLIATIVE GENERALISED 27
780 DEVICE MALFUNCTION 27
781 DEVICE RELATED INFECTION 27
782 HEPATOMEGALY 27
783 ISCHAEMIC CARDIOMYOPATHY 27
784 MULTIPLE INJURIES 27
785 MUSCLE ABSCESS 27
786 MUSCLE TWITCHING 27
787 NEPHROPATHY TOXIC 27
788 PERIPHERAL COLDNESS 27
789 POISONING 27
790 PRODUCT ADMINISTRATION INTERRUPTED 27
791 RENAL PAIN 27
792 SECONDARY ADRENOCORTICAL INSUFFICIENCY 27
793 SINUS BRADYCARDIA 27
794 VASCULAR PURPURA 27
795 VISUAL ACUITY REDUCED 27
796 CARDIAC VALVE DISEASE 26
797 CUSHINGOID 26
798 ECCHYMOSIS 26
799 FEEDING DISORDER 26
800 HAEMODIALYSIS 26
801 HAEMOLYSIS 26
802 HYPERTRIGLYCERIDAEMIA 26
803 HYPOPHOSPHATAEMIA 26
804 INJECTION SITE MASS 26
805 INTERNAL HAEMORRHAGE 26
806 INTERVERTEBRAL DISC DEGENERATION 26
807 LUNG INFILTRATION 26
808 LUPUS-LIKE SYNDROME 26
809 NEUTROPENIC SEPSIS 26
810 NOCTURIA 26
811 NODULE 26
812 OCULAR DISCOMFORT 26
813 OESOPHAGITIS 26
814 PNEUMONIA STREPTOCOCCAL 26
815 PNEUMOTHORAX 26
816 PROCEDURAL PAIN 26
817 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 26
818 PRODUCT STORAGE ERROR 26
819 PRURITUS GENERALISED 26
820 APPENDICITIS 25
821 ARTHRITIS BACTERIAL 25
822 AUTOINFLAMMATORY DISEASE 25
823 BLOOD MAGNESIUM DECREASED 25
824 BLOOD TEST ABNORMAL 25
825 CHOKING 25
826 CHONDROCALCINOSIS PYROPHOSPHATE 25
827 DERMATITIS CONTACT 25
828 DISABILITY 25
829 EMPHYSEMA 25
830 ENTERITIS 25
831 GLYCOSYLATED HAEMOGLOBIN INCREASED 25
832 HAEMOGLOBIN INCREASED 25
833 HAEMORRHAGIC ANAEMIA 25
834 INTERNATIONAL NORMALISED RATIO DECREASED 25
835 INTESTINAL PERFORATION 25
836 KNEE ARTHROPLASTY 25
837 LUNG INFECTION 25
838 MOUTH HAEMORRHAGE 25
839 PNEUMONIA BACTERIAL 25
840 POST PROCEDURAL COMPLICATION 25
841 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 25
842 SKIN LACERATION 25
843 SUBDURAL HAEMATOMA 25
844 TOOTH INFECTION 25
845 WHIPPLE^S DISEASE 25
846 ACUTE CORONARY SYNDROME 24
847 ATRIOVENTRICULAR BLOCK COMPLETE 24
848 BACTERAEMIA 24
849 BICYTOPENIA 24
850 BLOOD PRESSURE SYSTOLIC ABNORMAL 24
851 BRAIN NATRIURETIC PEPTIDE INCREASED 24
852 DERMATITIS ALLERGIC 24
853 DIPLOPIA 24
854 DRUG EFFECT LESS THAN EXPECTED 24
855 DRUG LEVEL DECREASED 24
856 FOOT DEFORMITY 24
857 IRRITABLE BOWEL SYNDROME 24
858 LOCAL SWELLING 24
859 MUSCLE STRAIN 24
860 ORAL CANDIDIASIS 24
861 PANIC ATTACK 24
862 POOR VENOUS ACCESS 24
863 PRODUCT AVAILABILITY ISSUE 24
864 SCAB 24
865 SPINAL PAIN 24
866 SUSPECTED SUICIDE 24
867 TRANSFUSION 24
868 X-LINKED LYMPHOPROLIFERATIVE SYNDROME 24
869 BEHCET'S SYNDROME 23
870 BREAST CANCER 23
871 BRONCHIECTASIS 23
872 BUNDLE BRANCH BLOCK LEFT 23
873 DEVICE DISLOCATION 23
874 ENTEROCOCCAL SEPSIS 23
875 EXTRAPYRAMIDAL DISORDER 23
876 GASTROINTESTINAL MOTILITY DISORDER 23
877 HAEMOLYTIC ANAEMIA 23
878 HEMIPARESIS 23
879 HERPES SIMPLEX 23
880 IMPAIRED QUALITY OF LIFE 23
881 INCREASED TENDENCY TO BRUISE 23
882 INFUSION SITE HAEMORRHAGE 23
883 LIPASE INCREASED 23
884 PLEUROPERICARDITIS 23
885 POLYNEUROPATHY 23
886 POTENTIATING DRUG INTERACTION 23
887 TEMPERATURE INTOLERANCE 23
888 TOOTH ABSCESS 23
889 TUMOUR LYSIS SYNDROME 23
890 TYPE IV HYPERSENSITIVITY REACTION 23
891 WOUND INFECTION 23
892 ANTINUCLEAR ANTIBODY POSITIVE 22
893 BLOOD IRON DECREASED 22
894 DEFAECATION URGENCY 22
895 DIARRHOEA HAEMORRHAGIC 22
896 EATING DISORDER 22
897 HEPATITIS CHOLESTATIC 22
898 HOSPICE CARE 22
899 INFLAMMATORY MARKER INCREASED 22
900 INFUSION SITE PRURITUS 22
901 MACULAR DEGENERATION 22
902 MIOSIS 22
903 NEEDLE ISSUE 22
904 OROPHARYNGEAL DISCOMFORT 22
905 PERIPHERAL VASCULAR DISORDER 22
906 POLYURIA 22
907 SKIN INDURATION 22
908 SQUAMOUS CELL CARCINOMA OF SKIN 22
909 SUPRAVENTRICULAR TACHYCARDIA 22
910 THYROID DISORDER 22
911 TYPE 2 LEPRA REACTION 22
912 UROSEPSIS 22
913 ACCIDENTAL EXPOSURE 21
914 APHONIA 21
915 BLOOD CHLORIDE DECREASED 21
916 CEREBRAL INFARCTION 21
917 CUSHING^S SYNDROME 21
918 DRUG ADMINISTRATION ERROR 21
919 DRUG LEVEL ABOVE THERAPEUTIC 21
920 FAILURE TO THRIVE 21
921 GASTROINTESTINAL PAIN 21
922 GROIN PAIN 21
923 GUILLAIN-BARRE SYNDROME 21
924 HIDRADENITIS 21
925 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 21
926 KLEBSIELLA INFECTION 21
927 LEFT VENTRICULAR HYPERTROPHY 21
928 LOWER LIMB FRACTURE 21
929 MATERNAL EXPOSURE TIMING UNSPECIFIED 21
930 MENTAL IMPAIRMENT 21
931 MOOD ALTERED 21
932 MULTIPLE ALLERGIES 21
933 MUSCLE TIGHTNESS 21
934 ORAL DISORDER 21
935 OSTEONECROSIS OF JAW 21
936 PARKINSON^S DISEASE 21
937 PERICARDITIS CONSTRICTIVE 21
938 PHARYNGEAL SWELLING 21
939 PLEURITIC PAIN 21
940 RESPIRATORY TRACT CONGESTION 21
941 RHINITIS 21
942 SEROTONIN SYNDROME 21
943 THIRST 21
944 TROPONIN I INCREASED 21
945 ACUTE PULMONARY OEDEMA 20
946 AORTIC STENOSIS 20
947 AUTOIMMUNE DISORDER 20
948 BACK DISORDER 20
949 COLITIS MICROSCOPIC 20
950 CYTOKINE RELEASE SYNDROME 20
951 DISTRIBUTIVE SHOCK 20
952 ERUCTATION 20
953 EXTRA DOSE ADMINISTERED 20
954 FEMUR FRACTURE 20
955 HYPERBILIRUBINAEMIA 20
956 HYPERLACTACIDAEMIA 20
957 INJECTION SITE EXTRAVASATION 20
958 IRON DEFICIENCY 20
959 JOINT NOISE 20
960 LABELLED DRUG-DRUG INTERACTION ISSUE 20
961 MATERNAL EXPOSURE DURING BREAST FEEDING 20
962 MONOCYTE COUNT INCREASED 20
963 MYOCARDIAL INJURY 20
964 NERVE INJURY 20
965 PSEUDOMONAS INFECTION 20
966 PYELONEPHRITIS 20
967 SKIN INFECTION 20
968 STAPHYLOCOCCAL SEPSIS 20
969 SYMPTOM RECURRENCE 20
970 TONGUE OEDEMA 20
971 VAGINAL HAEMORRHAGE 20
972 VASCULAR DEVICE INFECTION 20
973 VASOPLEGIA SYNDROME 20
974 ANAPHYLACTOID REACTION 19
975 ANGER 19
976 ANKLE FRACTURE 19
977 ARTERIAL OCCLUSIVE DISEASE 19
978 BLOOD CALCIUM INCREASED 19
979 BLOOD PHOSPHORUS INCREASED 19
980 BLOOD PRESSURE DIASTOLIC INCREASED 19
981 BRONCHOSPASM 19
982 CARDIAC PACEMAKER INSERTION 19
983 CORONARY ARTERY THROMBOSIS 19
984 COVID-19 PNEUMONIA 19
985 DEVICE LEAKAGE 19
986 EOSINOPHIL COUNT INCREASED 19
987 EYE PRURITUS 19
988 FISTULA 19
989 GANGRENE 19
990 GASTRIC HAEMORRHAGE 19
991 HEAD DISCOMFORT 19
992 HYPOALBUMINAEMIA 19
993 INSURANCE ISSUE 19
994 LUNG NEOPLASM MALIGNANT 19
995 LUNG OPACITY 19
996 PULMONARY THROMBOSIS 19
997 SKIN HYPERTROPHY 19
998 SKIN REACTION 19
999 SKIN TIGHTNESS 19